Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
307 artigos
New research reveals how fat tissue activates T cells, potentially explaining the link between obesity and inflammatory joint disease.
Analysis of measles epidemiology and public health implications heading into 2025
Icotrokinra, a breakthrough oral peptide targeting IL-23, demonstrates significant skin clearance in psoriasis with sustained benefits through 52 weeks.
Oral peptide targeting IL-23 receptor shows superior efficacy vs placebo and deucravacitinib in moderate-to-severe plaque psoriasis.
Clinical trial results for oral icotrokinra in treating plaque psoriasis across adult and adolescent patients published in NEJM.
New research reveals atopic dermatitis has multiple biological subtypes, each requiring personalized treatment approaches.
New research identifies Lp-PLA2 enzyme as therapeutic target for deadly lung disease affecting millions of workers worldwide.
Scientists develop potent α5β1 integrin inhibitor for inhalation therapy, offering new approach for severe asthma patients.
New spatial multiomics study maps cellular interactions in systemic sclerosis, revealing fibroblast-macrophage dynamics.
New research reveals how IL-35 therapy prevents neutrophil trap formation, offering hope for cigarette smoke-worsened asthma.
Review examines immunosuppressive drugs like cyclosporine and tacrolimus, highlighting new applications and safety management strategies.
New research reveals how IGF2BP3 protein promotes inflammation and tissue damage in rheumatoid arthritis through RNA modifications.
